(IXJ) iShares Global Healthcare - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642873255 • Health

IXJ: Pharmaceuticals, Biotechnology, Medical, Devices, Equipment, Services

The iShares Global Healthcare ETF, listed on NYSE ARCA under the ticker IXJ, is designed to track the performance of the global healthcare sector. To achieve this, the fund typically allocates at least 80% of its total assets to the component securities of its underlying index, which comprises companies deemed crucial to the healthcare sector by the index provider. Additionally, the fund may invest in other securities that exhibit economic characteristics substantially identical to those of the index's component securities, further enhancing its ability to mirror the sector's performance.

The underlying index of the iShares Global Healthcare ETF is constructed to measure the performance of companies that are considered part of the healthcare sector and are believed to be significant to global markets. This includes a broad range of healthcare-related businesses, such as pharmaceutical companies, biotechnology firms, healthcare equipment manufacturers, and healthcare service providers. By tracking this index, the ETF provides investors with exposure to the global healthcare sector, allowing them to potentially benefit from the growth and innovation within this industry.

In terms of its investment strategy, the iShares Global Healthcare ETF may also utilize derivatives, such as futures, options, and swap contracts, to manage its portfolio efficiently. Up to 20% of the fund's assets can be allocated to these instruments, as well as to cash and cash equivalents. This flexibility enables the fund managers to navigate market conditions effectively, ensuring that the ETF remains aligned with its underlying index and continues to provide investors with targeted exposure to the global healthcare sector. The fund is domiciled in the United States and is classified as an exchange-traded fund (ETF), specifically within the health category, with the ISIN US4642873255.

For more information about the iShares Global Healthcare ETF and other investment products, interested parties can visit the iShares website at http://www.ishares.com. This resource provides detailed information on the fund's performance, holdings, and investment objectives, as well as tools and insights for making informed investment decisions. By leveraging such resources, investors can better understand how the iShares Global Healthcare ETF fits into their overall investment strategy and how it can be used to gain exposure to the global healthcare sector.

Additional Sources for IXJ ETF

IXJ ETF Overview

Market Cap in USD 3,655m
Category Health
TER 0.42%
IPO / Inception 2001-11-13

IXJ ETF Ratings

Growth 5y 50.8%
Fundamental -
Dividend 52.1%
Rel. Strength Industry -94.9
Analysts -
Fair Price Momentum 80.53 USD
Fair Price DCF -

IXJ Dividends

Dividend Yield 12m 1.46%
Yield on Cost 5y 2.00%
Annual Growth 5y 5.79%
Payout Consistency 92.2%

IXJ Growth Ratios

Growth Correlation 3m -85.6%
Growth Correlation 12m 19.9%
Growth Correlation 5y 85.9%
CAGR 5y 6.57%
CAGR/Mean DD 5y 1.31
Sharpe Ratio 12m -0.20
Alpha -18.87
Beta 0.72
Volatility 12.24%
Current Volume 141.8k
Average Volume 20d 161.2k
What is the price of IXJ stocks?
As of January 23, 2025, the stock is trading at USD 88.51 with a total of 141,800 shares traded.
Over the past week, the price has changed by +1.29%, over one month by +2.04%, over three months by -7.35% and over the past year by +1.37%.
Is iShares Global Healthcare a good stock to buy?
Partly, yes. Based on ValueRay Analyses, iShares Global Healthcare (NYSE ARCA:IXJ) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 50.76 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IXJ as of January 2025 is 80.53. This means that IXJ is currently overvalued and has a potential downside of -9.02%.
Is IXJ a buy, sell or hold?
iShares Global Healthcare has no consensus analysts rating.
What are the forecast for IXJ stock price target?
According to ValueRays Forecast Model, IXJ iShares Global Healthcare will be worth about 88.7 in January 2026. The stock is currently trading at 88.51. This means that the stock has a potential upside of +0.25%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 88.7 0.2%